| Title: | Gender difference in the effects of COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI : results of the ISACS-STEMI COVID-19 registry |
|---|
| Authors: | ID De Luca, Giuseppe (Author)
ID Manzo-Silberman, Stephane (Author)
ID Algowhary, Magdy (Author)
ID Uguz, Berat (Author)
ID Oliveira, Dinaldo C. (Author)
ID Ganyukov, Vladimir (Author)
ID Busljetik, Oliver (Author)
ID Čerček, Miha (Author)
ID Okkels Jensen, Lisette (Author)
ID Loh, Poay Huan (Author)
ID Calmac, Lucian (Author), et al. |
|---|
| Files: |  URL - Source URL, visit https://www.mdpi.com/2077-0383/12/3/896
 PDF - Presentation file, download (896,48 KB)
MD5: D2C86B3C06261FB009DB332422890150
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: |  UKC LJ - Ljubljana University Medical Centre
|
|---|
| Abstract: | Background. Several reports have demonstrated the impact of the COVID-19 pandemic on the management and outcome of patients with ST-segment elevation myocardial infarction (STEMI). The aim of the current analysis is to investigate the potential gender difference in the effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI patients within the ISACS-STEMI COVID-19 Registry. Methods. This retrospective multicenter registry was performed in high-volume primary percutaneous coronary intervention (PPCI) centers on four continents and included STEMI patients undergoing PPCIs in March–June 2019 and 2020. Patients were divided according to gender. The main outcomes were the incidence and timing of the PPCI, (ischemia time ≥ 12 h and door-to-balloon ≥ 30 min) and in-hospital or 30-day mortality. Results. We included 16683 STEMI patients undergoing PPCIs in 109 centers. In 2020 during the pandemic, there was a significant reduction in PPCIs compared to 2019 (IRR 0.843 (95% CI: 0.825–0.861, p < 0.0001). We did not find a significant gender difference in the effects of the COVID-19 pandemic on the numbers of STEMI patients, which were similarly reduced from 2019 to 2020 in both groups, or in the mortality rates. Compared to prepandemia, 30-day mortality was significantly higher during the pandemic period among female (12.1% vs. 8.7%; adjusted HR [95% CI] = 1.66 [1.31–2.11], p < 0.001) but not male patients (5.8% vs. 6.7%; adjusted HR [95% CI] = 1.14 [0.96–1.34], p = 0.12). Conclusions. The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures similarly observed in both genders. Furthermore, we observed significantly increased in-hospital and 30-day mortality rates during the pandemic only among females. |
|---|
| Keywords: | gender, COVID-19, mortality, STEMI |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Year of publishing: | 2023 |
|---|
| Number of pages: | 15 str. |
|---|
| Numbering: | Vol. 12, iss. 3, [article no.] 896 |
|---|
| PID: | 20.500.12556/DiRROS-28585  |
|---|
| UDC: | 616.12 |
|---|
| ISSN on article: | 2077-0383 |
|---|
| DOI: | 10.3390/jcm12030896 |
|---|
| COBISS.SI-ID: | 272844291 |
|---|
| Note: | Nasl. z nasl. zaslona;
Opis vira z dne 24. 3. 2026;
|
|---|
| Publication date in DiRROS: | 24.03.2026 |
|---|
| Views: | 36 |
|---|
| Downloads: | 8 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
